MIGS – summarizing the evidence
Tuesday March 19, 2019
Across Canada, there has been a growing demand for and use of MIGS. However, the direct and indirect costs of MIGS can be considerable, and coverage under the public health insurance plans is inconsistent across jurisdictions. Therefore, the aim of the health technology assessment (HTA) was to inform the optimal use, including appropriate patient selection and funding, of MIGS devices and procedures for adults with glaucoma.
